Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Omaha-Council Bluffs, NE-IA MSA — September 2026
Omaha science talent is scarce even as the broader market cools.
Life sciences occupations show just 0.87 candidates per opening statewide even as Nebraska's broader unemployment rate holds at 2.9%, while metro Regulatory Affairs Specialist pay falls to $70,705 against a flat $104,000 national figure.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Science occupation candidate ratio: 0.87 — Candidates per opening, Life/Physical/Social Science roles (NE)
- Omaha metro unemployment: 2.6% — July 2026, vs 2.9% statewide, 4.1% national
- Regulatory Affairs Specialist pay gap: $70,705 vs $104,000 — Metro median down significantly vs stable national
- Nebraska biotech average salary: $82,040 — May 2026, below coastal biotech clusters
Key takeaways
Regulatory affairs pay drop looks like a mix shift, not a market cooling.
Metro Regulatory Affairs Specialist advertised pay fell significantly to $70,705 against a flat $104,000 national median, a gap too wide to explain by cost-of-living alone. National intelligence shows senior regulatory talent commanding $320K–$580K amid acute scarcity, suggesting Omaha postings are skewing toward junior roles while experienced talent gets retained quietly rather than advertised.
Clinical Data Manager and Biostatistician pay are moving in opposite directions locally.
Metro Clinical Data Manager pay rose significantly to $117,439 even as national pay fell, while metro Biostatistician pay fell significantly to $121,195 even as national pay rose. Divergence this sharp within closely related data-science functions suggests employer-specific hiring surges rather than a uniform metro trend — worth validating against specific open requisitions before resetting bands broadly.
Tight science-occupation supply complicates the build-versus-outsource calculus.
A 0.87 candidate-to-opening ratio for Life, Physical, and Social Science roles statewide means internal hiring timelines for R&D and quality functions may stretch longer than CDMO/CRO alternatives even when all-in cost favors building in-house. Current conditions suggest stress-testing headcount plans against realistic time-to-fill rather than historical hiring velocity.
Lower Nebraska biotech pay supports a retention argument, not just a cost argument.
Average Nebraska biotech salary of $82,040 sits well below coastal clusters, and Lincoln-area Associate Scientist roles ($54K–$83K) show meaningful headroom versus national biotech comp. Employers anchoring retention strategy purely on below-market cost risk losing experienced scientists to remote-eligible coastal employers now recruiting into secondary markets.
Median advertised pay by role — Omaha-Council Bluffs, NE-IA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $126,124 | $126,124 | Significant decline | $131,354 |
| Clinical Research Associate | $52,358 | $60,708 | $63,950 | Moderate increase | $90,956 |
| Lab Technician | $36,380 | $40,942 | $43,247 | Stable | $47,402 |
| Regulatory Affairs Specialist | $67,140 | $70,705 | $93,838 | Significant decline | $104,000 |
| Clinical Data Manager | $117,318 | $117,439 | $117,439 | Significant increase | $123,031 |
| Biostatistician * | $92,678 | $121,195 | $136,997 | Significant decline | $133,322 |
| Validation Engineer * | $78,870 | $80,220 | $80,220 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Omaha metro unemployment held at a historically tight 2.6% in July with Douglas County at 3.2%, even as Nebraska's broader labor market shows early signs of cooling, including softening private-industry employment outside construction, health care, and leisure. Life, Physical, and Social Science occupations statewide show just 0.87 candidates per opening — one of the tightest ratios of any occupational category tracked — signaling that scientific and regulatory talent scarcity, not headline unemployment, is the real constraint facing metro employers.
What it means
Tight science-occupation supply against a slowing broader economy means Life Sci leaders face a bifurcated market: general hiring leverage is improving while specialized scientific, regulatory, and CMC talent remains structurally scarce and expensive to replace. Falling advertised pay for Regulatory Affairs Specialist roles locally (down significantly to a $70,705 median versus a stable $104,000 national figure) may reflect fewer postings at senior levels rather than genuine easing, given national data showing VP Regulatory Affairs compensation still running $320K–$580K amid acute global scarcity. Consider reviewing regulatory affairs compensation bands at the senior and director level separately from entry-level postings, since metro advertised-pay movement may mask where true retention risk sits.
Looking ahead
Early indicator: October 20 brings Nebraska's September employment release, the first full read on whether the summer's private-industry slowdown is deepening. Watch whether health care and life sciences continue outpacing the broader slowdown or begin tracking it.
Worth watching: National September WARN activity included BioMarin (117 roles) and Bristol Myers (265 roles), concentrated in consolidation rather than execution functions. Track whether any displaced regulatory, quality, or CMC talent surfaces in the Omaha-area candidate pool given 64% of surveyed biopharma firms still actively recruiting nationally.
Emerging pressure point: Nebraska's minimum wage policy shift — fixed 1.75% annual increases replacing CPI-based adjustments starting January 2027 — compresses the gap between entry-level manufacturing and skilled technician pay over time. Monitor whether this narrows the pay premium needed to retain lab technicians and manufacturing operators against unskilled alternatives.
Potential inflection point: GLP-1 pipeline expansion continues pulling manufacturing, quality, and regulatory talent nationally toward specialty premiums, with Director CMC/Process Development reaching $220K–$520K. Watch whether this national pull begins drawing Nebraska-based CMC and manufacturing talent toward coastal or Midwest biomanufacturing hubs over the next two quarters.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.